Trial Profile
Phase I trial of FOV 2304 (safotibant).
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 Mar 2012
Price :
$35
*
At a glance
- Drugs Safotibant (Primary)
- Indications Diabetic macular oedema
- Focus Adverse reactions; Therapeutic Use
- 14 Oct 2009 New trial record.